Kymera Therapeutics, Inc.
Ticker: 1815442
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 65.00+89.1% | 34.37+1145.3% | 2.76-76.0% | 11.48-48.1% | 22.10+490.9% | 3.74-85.4% | 25.65+149.3% | 10.29 |
| Total Income | 65.00+89.1% | 34.37+1145.3% | 2.76-76.0% | 11.48-48.1% | 22.10+490.9% | 3.74-85.4% | 25.65+149.3% | 10.29 |
| EXPENSES | ||||||||
| Expenditure | 140.61+18.6% | 118.52+24.4% | 95.29-0.8% | 96.03-0.5% | 96.53+27.2% | 75.87-0.9% | 76.58+12.4% | 68.12 |
| PROFIT | ||||||||
| Net Profit | -61.21+11.6% | -69.23+15.8% | -82.18-7.3% | -76.61-16.8% | -65.58-4.9% | -62.49-48.6% | -42.06+13.4% | -48.56 |
| KEY METRICS | ||||||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -94.17%+5.83pp | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -0.62+12.7% | -0.71+24.5% | -0.94+1.1% | -0.95-15.9% | -0.82+0.0% | -0.82-41.4% | -0.58+15.9% | -0.69 |
Corporate Events
Board MeetingKYMR
202627Jul
Board Meeting
Terence Rooney appointed Chief Medical Officer, succeeding J…
SEC Filing ↗ Board MeetingKYMR
202624Jun
Board Meeting
Annual Meeting of Shareholders to vote on the election of Cl…
SEC Filing ↗ Board MeetingKYMR
202624Jun
Board Meeting
Felix J. Baker appointed Chairman of the Board, succeeding B…
SEC Filing ↗ Board MeetingKYMR
20268Jun
Board Meeting
Leadership Changes — Penny Carlson appointed as Senior Vice …
SEC Filing ↗